For decades, menstrual health was framed mainly around fertility. Are you ovulating? Can you get pregnant? But research over the past 20 years has reshaped that view. Today, many clinicians consider the menstrual cycle a “vital sign” - a monthly report on overall health.
Changes in timing, flow, or symptoms are not just reproductive details. They can reflect shifts in metabolism, cardiovascular risk, endocrine function, and even brain sensitivity to hormones. For women in their 20s, 40s, or 60s looking back on patterns over time, that perspective matters.
Here is what the evidence actually shows, and why it is relevant in real life.
Irregular or long cycles and future cardiometabolic risk
Large cohort studies, including data from the Nurses’ Health Study II published in JAMA Cardiology, have found that women with persistently irregular or long menstrual cycles face a higher risk of cardiovascular disease later in life. Earlier research also linked irregular cycles in young adulthood with increased risk of type 2 diabetes.
This does not mean that one off-cycle predicts heart disease. The key word is persistent. Ongoing irregularity may reflect underlying hormonal or metabolic patterns, including insulin resistance, that influence long-term cardiovascular health.
What your cycle may be saying:
If your periods are often more than 35 days apart, highly unpredictable, or markedly different from your long-standing pattern, it may be reasonable to pay attention to blood pressure, cholesterol, blood glucose, weight trends, and physical activity. Not as alarm, but as awareness.
Heavy, very frequent, or painful bleeding is not always “normal for you”
Soaking through pads or tampons every hour or two, passing large clots, or having cycles shorter than 21 days is commonly normalized. Many women adapt quietly.
The internationally used classification system helps clinicians identify causes of abnormal uterine bleeding. These range from conditions such as fibroids or polyps to ovulatory dysfunction, thyroid disorders, perimenopause, bleeding disorders, and, less commonly, malignancy. Heavy menstrual bleeding can also be the first clue to an inherited bleeding disorder or lead to iron-deficiency anemia.
What your cycle may be saying:
Bleeding patterns that disrupt daily life often signal something identifiable and frequently treatable. They are not simply a personal inconvenience to endure.
Cycle variability in your 40s: an early perimenopause signal
Menopause does not begin with the final period. Hormonal changes can start years earlier.
According to the STRAW+10 criteria used in research and clinical practice, a persistent difference of seven or more days between cycles, compared to previous between-the-cycles range, is an early marker of the menopausal transition. Cycles may shorten, lengthen, or become less predictable. Flow may change as well.
For many women, this stage overlaps with demanding life years. It is also a window for paying attention to sleep quality, mood shifts, bone health, and cardiovascular risk.
What your cycle may be saying:
If your periods begin to “jump around” in your 40s, this is often a biological transition rather than random chaos. It can be an opportunity to reassess broader health priorities, not just manage symptoms.
Infrequent or absent periods and PCOS
When periods occur only every few months, or stop altogether outside of pregnancy, it deserves evaluation.
Polycystic ovary syndrome (PCOS) is one of the most common causes of infrequent cycles (fewer than 6–8 periods per year). International evidence-based guidelines emphasize that PCOS is not only about fertility. It is associated with insulin resistance, higher risk of type 2 diabetes, and adverse lipid profiles. Symptoms may include acne, increased facial or body hair, or weight changes, though presentation varies.
What your cycle may be saying:
Widely spaced or absent periods can be an early metabolic signal. Identifying PCOS allows earlier attention to long-term health, including cardiometabolic risk and reproductive planning.
Severe premenstrual mood changes: brain sensitivity to hormones
For some women, the days before menstruation bring significant anxiety, depression, irritability, or mood instability. Premenstrual dysphoric disorder (PMDD) is now recognized in classification systems as a distinct and treatable condition.
Research suggests these symptoms are not caused by abnormal hormone levels, but by increased brain sensitivity to normal hormonal fluctuations.
What your cycle may be saying:
If mood reliably deteriorates before each period and then improves once bleeding begins, this is a biological pattern. Effective treatments exist, ranging from lifestyle strategies to targeted medications.
The menstrual cycle as a long-term health lens
A single irregular month rarely means something serious. Stress, travel, illness, weight changes, and exercise can all shift timing temporarily. The pattern over time is what matters.
Professional bodies such as the American College of Obstetricians and Gynecologists have encouraged clinicians to treat menstruation as a vital sign - a routine part of health assessment. While that guidance was framed for adolescents, the principle extends through adulthood.
A grounded takeaway for everyday life:
Know your usual pattern. Notice sustained changes in timing, flow, or symptoms. Bring them up at routine health visits, even if they seem unrelated to your main concern. Your menstrual cycle is not just about reproduction. It is ongoing information about your cardiovascular, metabolic, hormonal, and emotional health, and paying attention to it can support more informed, proactive care over time.
Norwegian version of the article can be found here:
Sources:
Wang YX, Stuart JJ, Rich-Edwards JW, et al. Menstrual Cycle Regularity and Length Across the Reproductive Lifespan and Risk of Cardiovascular Disease. JAMA Netw Open. 2022 Oct 3;5(10):e2238513.
Munro MG, Critchley HO, Fraser IS; FIGO Menstrual Disorders Working Group. The FIGO classification of causes of abnormal uterine bleeding in the reproductive years. Fertil Steril. 2011 Jun;95(7):2204-8, 2208.e1-3.
Hale GE, Robertson DM, Burger HG. The perimenopausal woman: endocrinology and management. J Steroid Biochem Mol Biol. 2014 Jul;142:121-31.
Harlow SD, Gass M, Hall JE, et al; STRAW 10 Collaborative Group. Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. Menopause. 2012 Apr;19(4):387-95.
Teede HJ, Misso ML, Costello MF, et al; International PCOS Network. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertil Steril. 2018 Aug;110(3):364-379.
Gao M, Zhang H, Gao Z, et al. Global and regional prevalence and burden for premenstrual syndrome and premenstrual dysphoric disorder: A study protocol for systematic review and meta-analysis. Medicine (Baltimore). 2022 Jan 7;101(1):e28528.
Schmidt PJ, Nieman LK, Danaceau MA, et al. Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. N Engl J Med. 1998 Jan 22;338(4):209-16.
ACOG Committee Opinion No. 651: Menstruation in Girls and Adolescents: Using the Menstrual Cycle as a Vital Sign. Obstet Gynecol. 2015 Dec;126(6):e143-e146
